Zobrazeno 1 - 10
of 56
pro vyhledávání: '"BAFF, B cell–activating factor"'
Publikováno v:
Frontiers in Nephrology, Vol 4 (2024)
Externí odkaz:
https://doaj.org/article/07ad04990ea14142bd2262fdbf6dba2b
Autor:
Vivien Hébert, Maud Maho-Vaillant, Marie-Laure Golinski, Marie Petit, Gaëtan Riou, Olivier Boyer, Philippe Musette, Sébastien Calbo, Pascal Joly
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
The efficacy of the B-cell-depleting agent rituximab has been reported in immune diseases but relapses are frequent, suggesting the need for repeated infusions. The B-cell activating factor (BAFF) is an important factor for B cell survival, class swi
Externí odkaz:
https://doaj.org/article/5f156bfa67434cb583c5df2e5491150c
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Externí odkaz:
https://doaj.org/article/07f73bfec470444d87fefaf891f9a149
Autor:
Cristian R. Smulski, Hermann Eibel
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
The BAFF-receptor (BAFFR) is encoded by the TNFRSF13C gene and is one of the main pro-survival receptors in B cells. Its function is impressively documented in humans by a homozygous deletion within exon 2, which leads to an almost complete block of
Externí odkaz:
https://doaj.org/article/fc5dc057f0c34c5b9e3a792a04aeec60
Publikováno v:
JAAD Case Reports
Psoriasis and lupus erythematosus (LE) are autoimmune diseases that affect the skin. Patients with these diseases may share a similar genetic predisposition, as genome-wide association studies have identified common genetic polymorphisms. Yet, the co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95d6a7f1dcfa4397f3c0b47160a2c4a6
https://doi.org/10.1016/j.jdcr.2019.05.022
https://doi.org/10.1016/j.jdcr.2019.05.022
Autor:
Philippe Musette, Maud Maho-Vaillant, Sébastien Calbo, Gaëtan Riou, Marie-Laure Golinski, Marie Anne Petit, Pascal Joly, Olivier Boyer, Vivien Hébert
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology, Vol 12 (2021)
The efficacy of the B-cell-depleting agent rituximab has been reported in immune diseases but relapses are frequent, suggesting the need for repeated infusions. The B-cell activating factor (BAFF) is an important factor for B cell survival, class swi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48f411efc3c41b6a85e7d1ac0c78e89c
https://pubmed.ncbi.nlm.nih.gov/34054835
https://pubmed.ncbi.nlm.nih.gov/34054835
Autor:
Jenny Lorena Molina Estupiñan, Stefania P. Bjarnarson, I. Jonsdottir, Audur Anna Aradottir Pind, Gudbjorg Julia Magnusdottir, Giuseppe Del Giudice
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Frontiers in Immunology
Frontiers in Immunology
Adjuvants enhance magnitude and duration of immune responses induced by vaccines. In this study we assessed in neonatal mice if and how the adjuvant LT-K63 given with a pneumococcal conjugate vaccine, Pnc1-TT, could affect the expression of tumor nec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2d2cfe93c48cc1de67b37d3c52d6696
https://www.frontiersin.org/articles/10.3389/fimmu.2020.527310/full
https://www.frontiersin.org/articles/10.3389/fimmu.2020.527310/full
Publikováno v:
JACC: Basic to Translational Science
Highlights • B cells regulate atherosclerotic plaque formation through production of antibodies and cytokines, and effects are subset specific (B1 and B2). • Putative human atheroprotective B1 cells function similarly to murine B1 in their sponta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b5376487935f3df0f95d6c4ee8944e91
https://pubmed.ncbi.nlm.nih.gov/34222726
https://pubmed.ncbi.nlm.nih.gov/34222726
Publikováno v:
Current Opinion in Endocrine and Metabolic Research
FFA2 and FFA3 are receptors for short-chain fatty acids which are produced in prodigious amounts by fermentation of poorly digested carbohydrates by gut bacteria. Understanding the roles of these receptors in regulating enteroendocrine, metabolic and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::927a31cd4f88a4cda1330d17432ffbff
https://pubmed.ncbi.nlm.nih.gov/32835130
https://pubmed.ncbi.nlm.nih.gov/32835130
Autor:
Carolina Ramírez-Santana, Yehuda Shoenfeld, Bernardo Camacho, Juan-Manuel Anaya, J. C. Diaz-Coronado, Yeny Acosta-Ampudia, Yhojan Rodríguez, Rubén Manrique, Rubén D. Mantilla, Juan E. Gallo, Manuel Rojas, Diana M. Monsalve, Adriana Rojas-Villarraga
Publikováno v:
Autoimmunity Reviews
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Repositorio Digital Institucional ReDi
Fundación Universitaria de Ciencias de la Salud-FUCS
instacron:Fundación Universitaria de Ciencias de la Salud-FUCS
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Repositorio Digital Institucional ReDi
Fundación Universitaria de Ciencias de la Salud-FUCS
instacron:Fundación Universitaria de Ciencias de la Salud-FUCS
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible of the coronavirus disease 2019 (COVID-19) pandemic. Therapeutic options including antimalarials, antivirals, and vaccines are under study. Meanwhile the current pandemic has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e202ca7aaa8ef2fc42bbe55ee39d72c
http://europepmc.org/articles/PMC7198427
http://europepmc.org/articles/PMC7198427